COVID ET QT : ETAT DES LIEUX

  • Service De Cardiologie, CHU Mohammed VI Marrakech.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Introduction During the current COVID-19 pandemic, there has been increased interest in using off-label medications for treatment of the novel coronavirus (SARS-CoV-2), including drugs with a propensity for QT prolongation such as hydroxychloroquine and azithromycin.(1) to evaluate and manage the QT interval in patients undergoing therapy Materials and methods: A prospective study of 156 Covid patients In all department of the Mohammed VI university hospital in Marrakech during the period from 1 April 2020 to 15 April 2020.

Résultats: 

Conclusion: Les thérapies pour COVID-19 peuvent entraiÌ‚ner des effets indésirables cardio- vasculaires aÌ€ la phase aiguë potentiellement graves et nécessitant une surveillance rapprochée surtout de l interval QT par l electrocardiogramme.

[M. Ztati, S. El Karimi and M. Elhattaoui (2023); COVID ET QT : ETAT DES LIEUX Int. J. of Adv. Res. 11 (Mar). 1589-1593] (ISSN 2320-5407). www.journalijar.com

ztati mohamed

Morocco

DOI:

Article DOI: 10.21474/IJAR01/16607      
DOI URL: https://dx.doi.org/10.21474/IJAR01/16607

Download Full Paper

Download PDF No. of Downloads: 8 | No. of Views: 33